EZH2 and central nervous system cancer: Additionally, the in vitro and in vivo experiments performed in our study revealed that MSC-derived exosomal miR-133b inhibited glioma cell proliferation, invasion, and migration and tumor growth by reducing EZH2 by inhibiting the Wnt/β-catenin signaling pathway.